SP600125

inquiry

Cat No.

CEI-0144

Description

SP600125 is a reversible ATP-competitive inhibitor which can inhibit JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM.

CAS_No

129-56-6

Molecular Weight

220.23

Purity

>99%

Storage

2 years at -20 centigrade

Targets

NK1, JNK2, JNK3

Molecular Formula

C14H8N2O

Chemical Name

2H-Dibenzo[cd,g]indazol-6-one

Solubility

DMSO 44 mg/mL Water

In vitro

SP600125 is a reversible ATP-competitive inhibitor which can inhibit JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM. SP600125 dose dependently inhibited the phosphorylation of c-Jun, the expression of inflammatory genes COX-2, IL-2, IFN-gamma, TNF-alpha, and prevented the activation and differentiation of primary human CD4 cell cultures. SP600125 is ATP-competitive (Ki=33 uM) but noncompetitive with substrate, GST-ATF2. SP600125 shows 10-fold selectivity (MKK4), 25-fold selectivity (MKK3, MKK6, PKB, and PKC-alpha),and 100-fold selectivity for other kinases. SP600125 blocks JNK and not other inflammatory-signaling cascades, and seems to have a selectivity of at least 10-fold for the JNK pathway.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry